Cullinan Therapeutics, Inc. CGEM
12.49 USD -3.26 (-20.70%)
At closeNov 4, 2026, 6:41 PM EST
12.30 -0.19 -1.52%
After hours · Nov 4, 6:41 PM ET
11.92 Day range 16.29
6.73 52-week range 23.19
- YTD
- +20.68%
- 1 year
- +68.78%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -241.65M | -196.92M | -191.09M | 144.65M | -67.95M | |
| -219.88M | -167.38M | -153.16M | 111.21M | -65.57M | |
| -3.36 | -2.78 | -3.21 | 2.38 | -1.52 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 88.33M | 83.00M | 98.43M | 156.15M | 59.77M | |
| 448.37M | 621.82M | 484.18M | 561.12M | 437.19M | |
| 39.64M | 31.50M | 30.29M | 26.09M | 11.81M | |
| 2.68M | 2.15M | 3.59M | 5.01M | 0 | |
| 408.73M | 590.33M | 453.70M | 535.03M | 424.97M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -175.75M | -145.30M | -134.28M | -126.66M | -43.43M | |
| 179.99M | -136.31M | 35.81M | 248.97M | -333.77M | |
| 1.09M | 266.19M | 40.75M | -25.93M | 268.78M | |
| -49.00K | 0 | -208.00K | -1.04M | 0 | |
| 5.33M | -15.43M | -57.72M | 96.38M | -108.42M |